Close Menu

Cancer Genetics

GSK and Abbott will develop a companion diagnostic for GSK's investigational MAGE-A3 immunotherapy. After discussions with the FDA, GSK believes the drug and diagnostic will be reviewed simultaneously, and labeling language for the drug will require genetic testing prior to treatment.

Snippets: Apr 1, 2009

Premium

Epigenomics, Response Genetics, Exact Sciences

The firm's Q4 revenues dropped 41 percent, but it noted that test sales are up in the first quarter.

The company said that shuttering the UK facility will save it around $2.3 million in annual expenses.

Snippets: Feb 4, 2009

Premium

National Institutes of Health, Genomic Health, Decode Genetics, Myriad Genetics, Exact Sciences, and more …

Roche will use Response Genetics' technology to assess a HER2 expression test.

Pages

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.